Patents Assigned to British Columbia Center for Disease Control
  • Publication number: 20180267020
    Abstract: Provided herein are methods of diagnosing and/or treating ACVS, by determining expression levels of several ACVS-related molecules, such as FABP3, ANPR-1, IGFBP-3, F9, SELL, apoB100, ADPN, vWF, THBS1, PRL, PON3, EGFR, VEGF-D, HPX, MBT, F5, F10, SERPIN A5, HCII, and HABP2, for example in a blood sample.
    Type: Application
    Filed: March 19, 2018
    Publication date: September 20, 2018
    Applicants: UVic Industry Partnerships Inc., Vancouver Island Health Authority, British Columbia Center for Disease Control, The Governors of the University of Calgary
    Inventors: Andrew Penn, Christoph Hermann Borchers, Mary Louise Lesperance, Angela Marie Jackson, Maximilian Barnaby Bibok, Viera Saly, Robert Fred Balshaw, Shelagh Brown Coutts